Status:
COMPLETED
A Nursing Support Intervention-based Project for Stroke Survivors
Lead Sponsor:
Institut de Recerca Biomèdica de Lleida
Conditions:
Stroke
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Stroke is the second single most common cause of death and the main cause of disability in the European Union (EU) region. Stroke victims face an uncertain future and a life severely affected by disab...
Detailed Description
It is estimated that 6 months after stroke, 45% of survivors have some type of functional dependence. The impact of stroke is quantified in disability adjusted life-years (DALYs), where DALY is 1 year...
Eligibility Criteria
Inclusion
- Ischaemic stroke or haemorrhagic stroke and NIHSS ≤ 5
- TIA with motor, speech or visual impairment
- Premorbid mRS\<4
- Event onset later than 72hr but within 14 days
- Medically-stable
- Consent-capable
Exclusion
- Advanced medical comorbidity (eg. dementia affecting basic activities of daily living, cancer, HIV, Hep B or C)
- Isolated sensory symptoms
- Aphasia
- Cognitive impairment
- Hearing loss
- Taking part in another study
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04746157
Start Date
March 15 2021
End Date
March 1 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRBLleida
Lleida, Spain, 25198